Effects of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and nonalcoholic fatty liver disease: A cohort study.

Saudi Pharm J · 2025 · PMC12559501 · PMID 41145880

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

This study showed a trend toward weight loss, and the difference was significant, as evidenced by the lower levels of VAT and SAT and lower BMI values in the SGLT2i group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.